Siddhartha Das P

About

Mr. Das Pramanik is currently pursuing his Ph.D. as a Research Scholar in the Department of Bioscience and Bioengineering at IIT Roorkee. His research focuses on cancer therapeutics, nanoformulations, bone disorders, and neurological diseases, with an emphasis on developing advanced and translational treatment strategies.

He has extensive experience in establishing and working with preclinical animal models, including cancer, osteoporosis, inflammation, cerebral stroke, neonatal hypoxia, post-traumatic stress disorder (PTSD), and Parkinson’s disease. His work reflects a strong commitment to bridging fundamental research with clinical relevance.

He holds an M. Pharm in Pharmacology from IIT (BHU), Varanasi, and a B. Pharm from Dr. B.C. Roy College of Pharmacy, Durgapur. Prior to his doctoral studies, he gained industry experience as a Territory Business Manager at Abbott Healthcare, Mumbai, and later served as an Assistant Professor at Adamas University, Kolkata, building a diverse background across academia and the pharmaceutical sector.

He is a life member of the Society of Pharmaceutical Education and Research (SPER). He was awarded a travel grant from IIT (BHU) to attend the “2nd World Congress on Neurological and Psychiatric Disorders” in Kuala Lumpur, Malaysia (2019). Additionally, he has been selected for the prestigious JST LOTUS Fellowship for a one-year research program in Tokyo, Japan.

His career vision is centered on advancing innovative therapeutics and contributing to impactful research in pharmaceutical, biotechnology and biomedical sciences.

Employment

• Tokyo University of Science Special Research Student
  2026 - Present
• Indian Institute of Technology Roorkee Research Scholar
  2021 - Present
• Adamas University Assistant Professor
  2021 - 2021

Education

• Indian Institute of Technology Roorkee Ph.D
  2021 - 2026
• Indian Institute of Technology (BHU) Varanasi M. Pharm
  2018 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• Utilization of Oxidovanadium(IV) Porphyrin as a Catalyst for One-Pot, Four-Component Synthesis of Bioactive Pyranopyrazoles and its Anticancer Potential.
  Inorganic chemistry 2026 DOI: 10.1021/acs.inorgchem.5c04384
  +Save
• Evaluation of Anticancer Potency of Copper(II) Complexes of 7-Hydroxycoumarin N(3)-Substituted Thiosemicarbazones
  Journal of the Brazilian Chemical Society 2026 DOI: 10.21577/0103-5053.20260128
  +Save
• Evaluation of anticancer potency of copper(II) complexes of 7-hydroxy coumarin N(3)-substituted thiosemicarbazones
  2026 DOI: 10.2139/ssrn.6232287
  +Save
• Synergistic combinatorial anticancer potential of Tamoxifen with Naringin and Diosmetin in MCF-7 breast cancer cells and their liposomal delivery.
  Scientific reports 2026 DOI: 10.1038/s41598-026-37954-5
  +Save
• Contributors
  Novel Drug Delivery Systems in the management of CNS Disorders 2025 DOI: 10.1016/b978-0-443-13474-6.01002-7
  +Save
• Novel treatment in managing autism
  Novel Drug Delivery Systems in the management of CNS Disorders 2025 DOI: 10.1016/b978-0-443-13474-6.00015-9
  +Save
• Structural dynamics and evaluation of anti-proliferative effects of di-n-butyltin and triphenyltin fluoroazosalicylates on DU-145 prostate cancer cells
  Journal of Molecular Structure 2025 DOI: 10.1016/j.molstruc.2024.140973
  +Save
• Deciphering the molecular interactions between monocyte chemoattractant protein and its potential inhibitor suramin.
  International journal of biological macromolecules 2025 DOI: 10.1016/j.ijbiomac.2025.141903
  +Save
• Author response for "NMR Elucidation of Structure-Dynamics-Function Relationship of Engineered CCL2 Chemokine Monomer"
  2025 DOI: 10.1002/mrc.70016/v2/response1
  +Save
• NMR Elucidation of Structure-Dynamics-Function Relationship of Engineered CCL2 Chemokine Monomer.
  Magnetic resonance in chemistry : MRC 2025 DOI: 10.1002/mrc.70016
  +Save